A mini review of biodegradable calcium phosphate nanoparticles for gene delivery

Current Pharmaceutical Biotechnology

Volumn 14, Issue 10, 2013, Pages 918-925

  Xie, Ying ^a   Chen, Yun ^a   Sun, Minjie ^a   Ping, Qineng ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Biodegradable; Calcium phosphate; Cellular uptake; Endosome escape; Gene delivery; Nanoparticles

Indexed keywords

CALCIUM PHOSPHATE; NANOPARTICLE;

APOPTOSIS; BIOAVAILABILITY; BIODEGRADABLE IMPLANT; CELL MIGRATION; CYTOTOXICITY; DNA DEGRADATION; ELECTRON SPIN RESONANCE; ENDOCYTOSIS; ENDOSOME; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; MICROEMULSION; REVIEW;

ANIMALS; BIOCOMPATIBLE MATERIALS; CALCIUM PHOSPHATES; CELL NUCLEUS; DNA; DRUG CARRIERS; ENDOCYTOSIS; ENDOSOMES; GENE TRANSFER TECHNIQUES; HUMANS; NANOPARTICLES; RNA, SMALL INTERFERING;

EID: 84896725980     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/1389201014666131226145441     Document Type: Review

References (62)

1. Oh, Y.-K.; Park, T.G. siRNA delivery systems for cancer treatment. Adv. Drug Deliv. Rev., 2009, 61(10), 850-862.
2. Dachs, G.U.; Dougherty, G.J.; Stratford, I.J.; Chaplin, D.J. Targeting gene therapy to cancer: A review. Oncolo. Res., 1997, 9(6-7), 313-325.
3. Mulligan, R. The basic science of gene therapy. Science, 1993, 260 (5110), 926-932.
4. Bumcrot, D.; Manoharan, M.; Koteliansky, V.; Sah, D.W. RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat. Chem. Biol., 2006, 2(12), 711-9.
5. Nishikawa, M.; Huang, L. Nonviral vectors in the new millennium: Delivery barriers in gene transfer. Human Gene Therapy, 2001, 12, 861-870.
6. Al-Dosari, M.S.; Gao, X. Nonviral gene delivery: Principle, limitations, and recent progress. AAPS J., 2009, 11(4), 671-81.
7. Li, S.D.; Huang, L. Gene therapy progress and prospects: non-viral gene therapy by systemic delivery. Gene Therap., 2006, 13(18), 1313-9.
8. Thomas, C.E.; Ehrhardt, A.; Kay, M.A. Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet., 2003, 4(5), 346-358.
9. Li, S.-D.; Huang, L. Non-viral is superior to viral gene delivery. J. Controlled Release, 2007, 123(3), 181-183.
10. Liu, F.; Huang, L. Development of non-viral vectors for systemic gene delivery. J. Controlled Release, 2002, 78(1-3), 259-266.
11. Ogris, M.; Brunner, S.; Schüller, S.; Kircheis, R.; Wagner, E. PEGylated DNA/transferrin-PEI complexes: Reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Therap., 1999, 6(4), 595-605.
12. Kalita, S.J.; Bhardwaj, A.; Bhatt, H.A. Nanocrystalline calcium phosphate ceramics in biomedical engineering. Mat. Sci. Eng. C, 2007, 27(3), 441-449.
13. Graham, F.L.; Erb, A.J.V. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology, 1973, 52, 456-467.
14. Bisht, S.; Bhakta, G.; Mitra, S.; Maitra, A. pDNA loaded calcium phosphate nanoparticles: highly efficient non-viral vector for gene delivery. Int. J. Pharm., 2005, 288(1), 157-168.
15. Li, J.; Chen, Y. C.; Tseng, Y. C.; Mozumdar, S.; Huang, L. Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery. J. Controlled Release: Official J. Controlled Release Soc., 2010, 142(3), 416-421.
16. Treves, S.; Franzini-Armstrong, C.; Moccagatta, L.; Arnoult, C.; Grasso, C.; Schrum, A.; Ducreux, S.; Zhu, M. X.; Mikoshiba, K.; Girard, T.; Smida-Rezgui, S.; Ronjat, M.; Zorzato, F. Junctate is a key element in calcium entry induced by activation of InsP3 receptors and/or calcium store depletion. J. Cell Biol., 2004, 166(4), 537-548.
17. Neumann, S.; Kovtun, A.; Dietzel, I.D.; Epple, M.; Heumann, R. The use of size-defined DNA-functionalized calcium phosphate nanoparticles to minimise intracellular calcium disturbance during transfection. Biomaterials, 2009, 30(35), 6794-6802.
18. Li, J.; Yang, Y.; Huang, L. Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor. J. Controlled Release: Official J. Controlled Release Soc., 2012, 158(1), 108-114.
19. Hu, Y.; Haynes, M.T.; Wang, Y.; Liu, F.; Huang, L. A highly efficient synthetic vector: nonhydrodynamic delivery of DNA to hepatocyte nuclei in vivo. ACS Nano, 2013, 7(6), 5376-5384.
20. Pittella, F.; Miyata, K.; Maeda, Y.; Suma, T.; Watanabe, S.; Chen, Q.; Christie, R. J.; Osada, K.; Nishiyama, N.; Kataoka, K. Pancreatic cancer therapy by systemic administration of VEGF siRNA contained in calcium phosphate/charge-conversional polymer hybrid nanoparticles. J. Controlled Release: Official J. Controlled Release Soc., 2012, 161(3), 868-874.
21. Olton, D.; Li, J.; Wilson, M. E.; Rogers, T.; Close, J.; Huang, L.; Kumta, P.N.; Sfeir, C. Nanostructured calcium phosphates (Nano- CaPs) for non-viral gene delivery: influence of the synthesis parameters on transfection efficiency. Biomaterials, 2007, 28(6), 1267-79.
22. Pedraza, C.E.; Bassett, D.C.; McKee, M.D.; Nelea, V.; Gbureck, U.; Barralet, J.E. The importance of particle size and DNA condensation salt for calcium phosphate nanoparticle transfection. Biomaterials, 2008, 29(23), 3384-92.
23. Lee, D.; Upadhye, K.; Kumta, P.N. Nano-sized calcium phosphate (CaP) carriers for non-viral gene deilvery. Mat. Sci. Eng.: B, 2012, 177(3), 289-302.
24. Pack, D.W.; Hoffman, A.S.; Pun, S.; Stayton, P.S. Design and development of polymers for gene delivery. Nat. Rev. Drug Discov., 2005, 4(7), 581-593.
25. Kakizawa, Y.; Kataoka, K. Block copolymer self-assembly into monodispersive nanoparticles with hybrid core of antisense DNA and calcium phosphate. Langmuir, 2002, 18(12), 4539-4543.
26. Giger, E.V.; Puigmarti-Luis, J.; Schlatter, R.; Castagner, B.; Dittrich, P.S.; Leroux, J.C. Gene delivery with bisphosphonatestabilized calcium phosphate nanoparticles. J. Controlled Release: Official J. Controlled Release Soc., 2011, 150(1), 87-93.
27. Lee, K.; Oh, M.H.; Lee, M.S.; Nam, Y.S.; Park, T.G.; Jeong, J.H. Stabilized calcium phosphate nano-aggregates using a dopachitosan conjugate for gene delivery. Int. J. Pharm., 2013, 445(1-2), 196-202.
28. Kakizawa, Y.; Miyata, K.; Furukawa, S.; Kataoka, K. Sizecontrolled formation of a calcium phosphate-based organic- inorganic hybrid vector for gene delivery using Poly(ethylene glycol)- block-poly(aspartic acid). Adv. Mat., 2004, 16(8), 699-702.
29. Kakizawa, Y.; Furukawa, S.; Kataoka, K. Block copolymer-coated calcium phosphate nanoparticles sensing intracellular environment for oligodeoxynucleotide and siRNA delivery. J. Controlled Release: Official J. Controlled Release Soc., 2004, 97(2), 345-356.
30. Kakizawa, Y.; Furukawa, S.; Ishii, A.; Kataoka, K. Organicinorganic hybrid-nanocarrier of siRNA constructing through the self-assembly of calcium phosphate and PEG-based block aniomer. J. Controlled Release: Official J. Controlled Release Soc., 2006, 111(3), 368-370.
31. Zhang, M.; Ishii, A.; Nishiyama, N.; Matsumoto, S.; Ishii, T.; Yamasaki, Y.; Kataoka, K. PEGylated calcium phosphate nanocomposites as smart environment-sensitive carriers for siRNA delivery. Adv. Mat., 2009, 21(34), 3520-3525.
32. Pittella, F.; Zhang, M.; Lee, Y.; Kim, H. J.; Tockary, T.; Osada, K.; Ishii, T.; Miyata, K.; Nishiyama, N.; Kataoka, K. Enhanced endosomal escape of siRNA-incorporating hybrid nanoparticles from calcium phosphate and PEG-block charge-conversional polymer for efficient gene knockdown with negligible cytotoxicity. Biomaterials, 2011, 32(11), 3106-3114.
33. Giger, E.V.; Castagner, B.; Raikkonen, J.; Monkkonen, J.; Leroux, J.C. siRNA transfection with calcium phosphate nanoparticles stabilized with PEGylated chelators. Adv. Healthcare Mat., 2013, 2(1), 134-44.
34. Jang, S.; Lee, S.; Kim, H.; Ham, J.; Seo, J.-H.; Mok, Y.; Noh, M.; Lee, Y. Preparation of pH-sensitive CaP nanoparticles coated with a phosphate-based block copolymer for efficient gene delivery. Polymer, 2012, 53(21), 4678-4685.
35. Maeda, H.; Sawa, T.; Konno, T. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J. Controlled Release, 2001, 74(1-3), 47-61.
36. Harrington, K.J.; Mohammadtaghi, S.; Uster, P.S.; Glass, D.; Peters, A.M.; Vile, R.G.; Stewart, J.S.W. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin. Cancer Res., 2001, 7(2), 243-254.
37. Mishra, S.; Webster, P.; Davis, M.E. PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles. Eur. J. Cell Biol., 2004, 83(3), 97-111.
38. Remaut, K.; Lucas, B.; Braeckmans, K.; Demeester, J.; De Smedt, S.C. Pegylation of liposomes favours the endosomal degradation of the delivered phosphodiester oligonucleotides. J. Controlled Release, 2007, 117(2), 256-266.
39. Hatakeyama, H.; Akita, H.; Harashima, H. A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: A strategy for overcoming the PEG dilemma. Adv. Drug Deliv Rev., 2011, 63(3), 152-160.
40. Lai, C.; Tang, S.; Wang, Y.; Wei, K. Formation of calcium phosphate nanoparticles in reverse microemulsions. Mat. Lett., 2005, 59 (2-3), 210-214.
41. Roy, I.; Mitra, S.; Maitra, A.; Mozumdar, S. Calcium phosphate nanoparticles as novel non-viral vectors for targeted gene delivery. Int. J. Pharm., 2003, 250(1), 25-33.
42. Sokolova, V. V.; Radtke, I.; Heumann, R.; Epple, M. Effective transfection of cells with multi-shell calcium phosphate-DNA nanoparticles. Biomaterials, 2006, 27(16), 3147-53.
43. Lasic, D.D.; Templeton, N.S. Liposomes in gene therapy. Adv. Drug Delivery Rev., 1996, 20(2-3), 221-266.
44. Li, S.; Huang, L. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Therap., 1997, 4(9), 891-900.
45. Li, S.F.; Rizzo, M.A.; Rizzo, M.F.; Bhattacharya, S.; Bhattacharya S.F.; Huang, L.; Huang, L. Characterization of cationic lipidprotamine- DNA (LPD) complexes for intravenous gene delivery. (0969-7128 (Print)).
46. Li, S.-D.; Chen, Y.-C.; Hackett, M.J.; Huang, L. Tumor-targeted delivery of siRNA by self-assembled nanoparticles. Mol. Ther., 2007, 16(1), 163-169.
47. Alexis, F.; Pridgen, E.; Molnar, L.K.; Farokhzad, O.C. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharmaceut., 2008, 5(4), 505-515.
48. Hafez, I.; Maurer, N.; Cullis, P. On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids. Gene Therap., 2001, 8(15), 1188-1196.
49. Liu, F.; Song, Y.; Liu, D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Therap., 1999, 6(7), 1258.
50. Zhou, C.; Yu, B.; Yang, X.; Huo, T.; Lee, L.J.; Barth, R.F.; Lee, R.J. Lipid-coated nano-calcium-phosphate (LNCP) for gene delivery. Int. J. Pharmaceut., 2010, 392(1-2), 201-208.
51. Batard, P.; Jordan, M.; Wurm, F. Transfer of high copy number plasmid into mammalian cells by calcium phosphate transfection. Gene, 2001, 270(1-2), 61-68.
52. Sahay, G.; Alakhova, D.Y.; Kabanov, A.V. Endocytosis of nanomedicines. J. Controlled Release, 2010, 145(3), 182-195.
53. Olton, D.Y.; Close, J.M.; Sfeir, C.S.; Kumta, P.N. Intracellular trafficking pathways involved in the gene transfer of nanostructured calcium phosphate-DNA particles. Biomaterials, 2011, 32(30), 7662-70.
54. Sokolova, V.; Kozlova, D.; Knuschke, T.; Buer, J.; Westendorf, A. M.; Epple, M. Mechanism of the uptake of cationic and anionic calcium phosphate nanoparticles by cells. Acta Biomaterialia, 2013, 9(7), 7527-7535.
55. Thomas, M.; Klibanov, A.M. Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells. Proc. Nat. Acad. Sci., 2002, 99(23), 14640-14645.
56. Dean, D.; Strong, D.; Zimmer, W. Nuclear entry of nonviral vectors. Gene Therap., 2005, 12(11), 881-890.
57. Tkachenko, A.G.; Xie, H.; Coleman, D.; Glomm, W.; Ryan, J.; Anderson, M.F.; Franzen, S.; Feldheim, D.L. Multifunctional gold nanoparticle-peptide complexes for nuclear targeting. J. Am. Chem. Soc., 2003, 125(16), 4700-4701.
58. Pan, L.; He, Q.; Liu, J.; Chen, Y.; Ma, M.; Zhang, L.; Shi, J. Nuclear- targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles. J. Am. Chem. Soc., 2012, 134(13), 5722-5725.
59. Maitra, A. Calcium phosphate nanoparticles: Second-generation nonviral vectors in gene therapy. Exp. Rev. Molecul. Diagnost., 2005, 5(6), 893-905.
60. Mattson, M.P.; Chan, S.L. Calcium orchestrates apoptosis. Nat. Cell Biol., 2003, 5(12), 1041-1043.
61. McConkey, D.J.; Orrenius, S. The role of calcium in the regulation of apoptosis. Biochem. Biophys. Res. Comm., 1997, 239(2), 357-366.
62. Tseng, Y.-C.; Yang, Q.; Huang, L. How does the cell overcome LCP nanoparticle-induced calcium toxicity? Mol. Pharm., 2013, 10(11), 439-4395.